Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Barrett

Showing results (201-210 of 349) with videos related to

Pageof 35
Sort By:
Blood|November 12, 2005
Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidenceMinoo Battiwalla, Theresa Hahn, Marija Radovic, et al.
British Journal of Haematology|March 5, 2003
Prospective evaluation of cell kinetics, yields and donor experiences during a single large-volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cellsCharles D Bolan, Charles S Carter, Robert A Wesley, et al.
Cancer Immunology Research|April 30, 2014
Gene-modified human α/β-T cells expressing a chimeric CD16-CD3ζ receptor as adoptively transferable effector cells for anticancer monoclonal antibody therapyFumihiro Ochi, Hiroshi Fujiwara, Kazushi Tanimoto, et al.
Blood|August 15, 2002
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndromeYogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
New developments in allotransplant immunologyA John Barrett, Katayoun Rezvani, Scott Solomon, et al.
Infection and Immunity|April 23, 2004
Binding of hematin by a new class of glutathione transferase from the blood-feeding parasitic nematode Haemonchus contortusArjan J van Rossum, James R Jefferies, Frans A M Rijsewijk, et al.
Blood|April 22, 2006
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCTKatayoun Rezvani, Stephan Mielke, Mojgan Ahmadzadeh, et al.
The Lancet. Oncology|October 4, 2005
Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinibBipin N Savani, Ramaprasad Srinivasan, Igor Espinoza-Delgado, et al.
Blood|April 14, 2005
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndromeElaine M Sloand, Lori Mainwaring, Monika Fuhrer, et al.
Blood|January 26, 2010
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantationAndreas T Björklund, Marie Schaffer, Cyril Fauriat, et al.
Pageof 35

Showing results (201-210 of 349) with videos related to

Sort By:
Pageof 35
Blood|November 12, 2005
Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidenceMinoo Battiwalla, Theresa Hahn, Marija Radovic, et al.
British Journal of Haematology|March 5, 2003
Prospective evaluation of cell kinetics, yields and donor experiences during a single large-volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cellsCharles D Bolan, Charles S Carter, Robert A Wesley, et al.
Cancer Immunology Research|April 30, 2014
Gene-modified human α/β-T cells expressing a chimeric CD16-CD3ζ receptor as adoptively transferable effector cells for anticancer monoclonal antibody therapyFumihiro Ochi, Hiroshi Fujiwara, Kazushi Tanimoto, et al.
Blood|August 15, 2002
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndromeYogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
New developments in allotransplant immunologyA John Barrett, Katayoun Rezvani, Scott Solomon, et al.
Infection and Immunity|April 23, 2004
Binding of hematin by a new class of glutathione transferase from the blood-feeding parasitic nematode Haemonchus contortusArjan J van Rossum, James R Jefferies, Frans A M Rijsewijk, et al.
Blood|April 22, 2006
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCTKatayoun Rezvani, Stephan Mielke, Mojgan Ahmadzadeh, et al.
The Lancet. Oncology|October 4, 2005
Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinibBipin N Savani, Ramaprasad Srinivasan, Igor Espinoza-Delgado, et al.
Blood|April 14, 2005
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndromeElaine M Sloand, Lori Mainwaring, Monika Fuhrer, et al.
Blood|January 26, 2010
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantationAndreas T Björklund, Marie Schaffer, Cyril Fauriat, et al.
Pageof 35